Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer, Cancer spread to the brain, Cancer spread to the liver, Cancer spread to the lung, Secondary cancers
Closed
Phase 1/2
This study is looking at trastuzumab deruxtecan by itself and with other cancer drugs for breast cancer. It is open to people with breast cancer that has spread to another part of the body and has large amounts of HER2.
Recruitment start: 1 February 2022
Recruitment end: 21 February 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Hartmut Kristeleit
AstraZeneca
Last reviewed: 14 Jun 2023
CRUK internal database number: 18221
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
